A hormone treatment called tesamorelin slightly raises long-term blood sugar levels by 0.19% more than a placebo in people with HIV after six months of treatment.

73

Pro

0

Against

Evidence from Studies

Supporting (1)

73

Community contributions welcome

73

Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial.

Randomized Controlled Trial

Human

2014 Jul 23-30

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Source Study

Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial.

Score: 73

DOI: 10.1001/jama.2014.8334

Similar Assertions

Tesamorelin boosts a key growth hormone-related protein in HIV patients without affecting their blood sugar levels.

81

0

73%

A hormone treatment called tesamorelin raises IGF-1 hormone levels more than a placebo in people with HIV at 2 weeks, 3 months, and 6 months of treatment.

73

0

70%